报价延迟最少15分钟:2026/05/13 17:39 EDT
盘后时段
|
||||
|
23.2958 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
23.32
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-5.55/1.85
|
|
企业价值
185.73M
|
| 资产负债 |
|
每股账面净值
11.70
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
118.71M
|
|
每股收益
26.00
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers. |
